Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus

Table 2 Association of miR-26a levels with baseline characteristics

	Exp(B) (95 % CI)	p value
Age	0.981 (0.932–1.033)	0.465
Male sex	1.306 (0.409–4.174)	0.652
Body mass index	1.062 (0.950–1.186)	0.291
Coronary artery disease	2.320 (1.047–5.138)	0.038
Arterial hypertension	0.632 (0.205–1.953)	0.426
Hyperlipoproteinemia	1.179 (0.445–3.123)	0.740
Smoking	0.808 (0.247–2.641)	0.725
Chronic kidney disease	1.101 (0.081–14.961)	0.943
Angiotensin Converting Enzyme Inhibitors (ACEI)	1.404 (0.440–4.482)	0.566
Angiotensin receptor blockers (ARB)	0.970 (0.269–3.495)	0.963
Calcium channel blockers (CCB)	1.566 (0.565–4.339)	0.389
Diuretics	0.551 (0.252–1.205)	0.135
Statins	0.615 (0.185–2.037)	0.426
Nitrates	1.492 (0.215–10.347)	0.685
Aspirin	0.664 (0.196–2.248)	0.510
Clopidogrel	0.675 (0.293–1.558)	0.358

The coefficient of the continuous variables was relative to 1-U differences. Binary logistic regression according to the median of miR-26a level
Exp(B) exponentiation of the B coefficient, miR microRNA
Italic value indicates significance of p value (p < 0.05)

ISSN: 1475-2840